ROLE OF PNPLA3, TM6SF2 AND GCKR POLYMORPHISMS IN HEPATIC STEATOSIS IN WILSON'S DISEASE

被引：0
|
作者：
Loddo, E. [1 ]
Giglio, C. [1 ]
Civolani, A. [2 ]
Sorbello, O. [2 ]
Mocci, S. [1 ]
Mancuso, G. [1 ]
Faa, G. [1 ]
Onali, S. [1 ]
Giglio, S. R. [1 ]
Fantini, M. C. [1 ]
机构：
[1] Univ Cagliari, Dipartimento Sci Med & Sanita Pubbl, Cagliari, Italy
[2] Azienda Osped Univ Cagliari, UOC Gastroenterol, Cagliari, Italy
来源：
DIGESTIVE AND LIVER DISEASE | 2022年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
T.08.2
引用
收藏
页码：S147 / S147
页数：1
相关论文
共 50 条
  • [1] ASSOCIATION OF FNDC5, PNPLA3 AND TM6SF2 POLYMORPHISMS WITH HEPATIC STEATOSIS IN NAFLD PATIENTS
    Miki, Daiki
    Nakahara, Takashi
    Murakami, Eisuke
    Abe-Chayama, Hiromi
    Fujino, Hatsue
    Ono, Atsushi
    Yamauchi, Masami
    Kawaoka, Tomokazu
    Tsuge, Masataka
    Hiramatsu, Akira
    Imamura, Michio
    Aikata, Hiroshi
    Hayes, Nelson
    Makokha, Grace Naswa
    Tsunoda, Tatsuhiko
    Chayama, Kazuaki
    HEPATOLOGY, 2019, 70 : 1050A - 1051A
  • [2] PNPLA3 and TM6SF2 Risk Alleles Amplify Effects of Diet on Hepatic Steatosis
    Chen, Vincent L.
    Du, Xiaomeng
    Chen, Yanhua
    Kuppa, Annapurna
    Halligan, Brian
    Speliotes, Elizabeth
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S549 - S549
  • [3] PNPLA3 and TM6SF2 polymorphisms in Brazilian patients with nonalcoholic fatty liver disease
    Lisboa, Quelson Coelho
    Nardelli, Mateus Jorge
    Pereira, Patricia de Araujo
    Miranda, Debora Marques
    Ribeiro, Stephanie Nunes
    Costa, Raissa Soares Neves
    Versiani, Camila Azevedo
    Vidigal, Paula Vieira Teixeira
    Ferrari, Teresa Cristina de Abreu
    Couto, Claudia Alves
    WORLD JOURNAL OF HEPATOLOGY, 2020, 12 (10) : 792 - 806
  • [4] PNPLA3 and TM6SF2 polymorphisms in Brazilian patients with nonalcoholic fatty liver disease
    Quelson Coelho Lisboa
    Mateus Jorge Nardelli
    Patrícia de Araújo Pereira
    Débora Marques Miranda
    Stephanie Nunes Ribeiro
    Raissa Soares Neves Costa
    Camila Azevedo Versiani
    Paula Vieira Teixeira Vidigal
    Teresa Cristina de Abreu Ferrari
    Claudia Alves Couto
    World Journal of Hepatology, 2020, (10) : 792 - 806
  • [5] Hepatic steatosis in Wilson disease - Role of copper and PNPLA3 mutations
    Staettermayer, Albert Friedrich
    Traussnigg, Stefan
    Dienes, Hans-Peter
    Aigner, Elmar
    Stauber, Rudolf
    Lackner, Karoline
    Hofer, Harald
    Stift, Judith
    Wrba, Friedrich
    Stadlmayr, Andreas
    Datz, Christian
    Strasser, Michael
    Maieron, Andreas
    Trauner, Michael
    Ferenci, Peter
    JOURNAL OF HEPATOLOGY, 2015, 63 (01) : 156 - 163
  • [6] The Genetics of Nonalcoholic Fatty Liver Disease: Spotlight on PNPLA3 and TM6SF2
    Anstee, Quentin M.
    Day, Christopher P.
    SEMINARS IN LIVER DISEASE, 2015, 35 (03) : 270 - 290
  • [7] PNPLA3 but not TM6SF2 polymorphisms were associated with higher degrees of steatosis and liver fibrosis among Brazilian NAFLD patients
    Mazo, Daniel F.
    Malta, Fernanda
    Stefano, Jose Tadeu
    Salles, Ana Paula M.
    Gomes-Gouvea, Michele S.
    Nastri, Ana Catharina S.
    Almeida, Jazon Romilson S.
    Pinho, Joao Renato R.
    Carrilho, Flair J.
    Oliveira, Claudia P.
    HEPATOLOGY, 2017, 66 : 1159A - 1159A
  • [8] The FTO, PNPLA3 and TM6SF2 Gene Polymorphisms and Genetic Predisposition to NAFLD in Yakut Population
    Diakonova, Aleksandra T.
    Kurtanov, Khariton A.
    Pavlova, Nadezhda I.
    Aleksandrova, Tuyara N.
    INTERNATIONAL JOURNAL OF BIOMEDICINE, 2021, 11 (01) : 92 - 95
  • [9] PNPLA3, TM6SF2 and MBOAT7 genotypes and coronary artery disease
    Simons, N.
    Isaacs, A.
    Koek, G. H.
    Kuc, S.
    Schaper, N. C.
    Brouwers, M. C.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S428 - S428
  • [10] Association of PNPLA3 and TM6SF2 Polymorphisms with NAFLD in Greek People with Type 2 Diabetes Mellitus
    Meritsi, Angeliki
    Rapti, Stamatia
    Latsou, Dimitra
    Tsorlalis, Ioannis
    Manesis, Emanuel
    Kousis, Panagiotis
    Zoumpoulis, Pavlos
    Thanopoulou, Anastasia
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2023, 142 : S10 - S10
12345